Yi (lily) Li

Eli Lilly engages in the discovery, development, manufacture, and sale of pharmaceutical products.

Raised $6,500,000.00.

Inspirna is a biotechnology company developing drugs for the treatment of cancer.

Raised $144,596,738.00 from The New York City Investment Fund, Sixty Degree Capital, Sofinnova Partners, Dreavent 6, Novo Holdings, Sands Capital Ventures, Vivo Capital and Lepu Medical.

Libra Therapeutics is a biotechnology company.

Raised $29,000,000.00 from Yonjin Venture, Sante Ventures, Dolby Family Ventures, Sixty Degree Capital, Epidarex Capital and Boehringer Ingelheim Venture Fund.

Strive Health is a value-based kidney care provider with an integrated system supporting the journey of individuals with kidney disease.

Raised $386,000,000.00 from Town Hall Ventures, New Enterprise Associates, Ascension Ventures, CapitalG, Echo Health Ventures, Redpoint and CVS Health Ventures.

NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.

Raised $122,500,000.00 from Leaps by Bayer, Invus, Arkin Holdings, Gordon Freeman, WTT Investment, Binney Street Capital, Sixty Degree Capital, Sanofi Ventures, MPM Capital and Catalio Capital Management.

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

Raised $277,500,000.00 from Tri Locum Partners, Deep Track Capital, Rock Springs Capital, Atlas Venture, New Enterprise Associates and Blue Owl.

Turnstone Biologics is a privately-held clinical stage biotech company.

Raised $132,699,979.00 from Brace Pharma, Ridgeback Capital, PFM Health Sciences, Point72, Northleaf Capital Partners, Surveyor Capital, Sixty Degree Capital, Teralys Capital, JM Family Enterprises and Versant Ventures.

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

Raised $200,399,999.00 from EPIQ Capital Group, Altium Capital, Domain Associates, Heartland Healthcare Capital, Pontifax, GRA Venture Fund, GordonMD Global Investments, Avego Bioscience Capital, Fonds de solidarité FTQ and Amzak Health Investors.